GlassScriptPhysician profile
Cindy Szeto
NPI 1528083649
$6,535.52
in general payments reported to CMS, 2019-2025
10 companies · $1,610 in 2025
The $1,610 reported for 2025 was more than what 95% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,112 · 2020: $965 · 2021: $216 · 2022: $1,244 · 2023: $147 · 2024: $243 · 2025: $1,610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,523 · Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,522.67 |
| Food and Beverage | $476.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,836.84 | 2019-2024 | Dailies Total1, Precision 1, Total30 |
| Johnson & Johnson Vision Care, INC. | $2,662.26 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $311.05 | 2019-2021 | |
| Abb Con-Cise Optical Group LLC | $273.62 | 2019-2022 | |
| Coopervision INC. | $187.79 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $88.32 | 2022-2025 | Infuse, Miebo, Blink Nutritears |
| Visioneering Technologies, INC. | $57.14 | 2025 | |
| Alcon Research LLC | $52.56 | 2019 | |
| Sight Sciences, INC. | $38.05 | 2019 | |
| Abbvie INC. | $27.89 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Szeto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.